Two Genetic Mutations Linked to Tumor Behavior in Thyroid Cancer Patients
CDC27 mutations may be associated with less aggressive behavior while SLC25A5 mutations may be associated with more aggressive behavior in papillary thyroid carcinomas.
CDC27 mutations may be associated with less aggressive behavior while SLC25A5 mutations may be associated with more aggressive behavior in papillary thyroid carcinomas.
However, nearly one-third of patients develop lifelong complications following thyroid surgery.
Positive link to papillary, follicular, anaplastic thyroid cancer; inverse link for medullary thyroid cancer.
Cervical lymph node metastases are associated with compromised survival in young patients with papillary thyroid cancer.
HABP2 G534E variant is a susceptibility gene for familial nonmedullary thyroid cancer and functions as a dominant-negative tumor-suppressor gene.
Timing of radioactive iodine ablation doesn’t affect overall survival in papillary thyroid cancer.
A trained scent dog was able to accurately identify thyroid cancer in urine samples from patients with thyroid nodules.
Kenneth D. Burman, MD, discusses one study suggesting that the optimal time for repeat evaluation of benign thyroid nodules is 2 to 4 years.
A blood assay that measures BRAF mutation levels may be helpful in diagnosing and monitoring papillary thyroid cancer.
Radioactive iodine therapy may slightly improve survival in papillary thyroid carcinoma.